Brief: Australian Clinical Labs Provides Update on ACCC Review Timeline On Takeover Offer for Healius

Australian Clinical Labs

22/09/2023 24:59

Sept 22 (Reuters) - Australian Clinical Labs Ltd
 ACL.AX :
    * ACL:TAKEOVER OFFER FOR HEALIUS-UPDATE - ACCC REVIEW
TIMELINE,ACL
    * REFERS TO ITS OFF-MARKET TAKEOVER OFFER FOR ALL OF FULLY
PAID
ORDINARY SHARES ON ISSUE IN HEALIUS LIMITED
    * NOTES THAT ACCC HAS ADVISED ACL THAT IT HAS SUSPENDED
TIMELINE
ON ITS PUBLIC REGISTER OF ITS REVIEW OF PROPOSED MERGER
    * ACCC HAS NOT YET PUBLICLY STATED OR ADVISED ACL OF ITS NEW
EXPECTED DECISION DATE
    * EFFECT OF SUSPENSION OF TIMELINE THAT DATE ACCC EXPECTS TO
ANNOUNCE FINAL DECISION ON PROPOSED MERGER WILL BE DELAYED

Source text for Eikon:  ID:nASX4XTDgL 
Further company coverage:  ACL.AX 

 ((Reuters.Briefs@thomsonreuters.com;))